Promotion of astrocyte-neuron glutamate-glutamine shuttle by SCFA contributes to the alleviation of Alzheimer's disease.

[1]  M. Tremblay,et al.  Brief exposure of neuronal cells to levels of SCFAs observed in human systemic circulation impair lipid metabolism resulting in apoptosis , 2022, Scientific Reports.

[2]  A. Macpherson,et al.  Microbiota-derived acetate enables the metabolic fitness of the brain innate immune system during health and disease. , 2021, Cell metabolism.

[3]  Jin Chang,et al.  A dual-targeted multifunctional nanoformulation for potential prevention and therapy of Alzheimer's disease , 2021, Innovation.

[4]  Kai Li,et al.  Sodium butyrate ameliorates the impairment of synaptic plasticity by inhibiting the neuroinflammation in 5XFAD mice. , 2021, Chemico-biological interactions.

[5]  M. Dichgans,et al.  Microbiota-derived short chain fatty acids modulate microglia and promote Aβ plaque deposition , 2021, eLife.

[6]  Lihua Zhang,et al.  Inference and analysis of cell-cell communication using CellChat , 2020, Nature Communications.

[7]  A. Regev,et al.  Single cell RNA sequencing of human microglia uncovers a subset associated with Alzheimer’s disease , 2020, Nature Communications.

[8]  M. Mattson,et al.  Brain energy rescue: an emerging therapeutic concept for neurodegenerative disorders of ageing , 2020, Nature Reviews Drug Discovery.

[9]  Yue Wang,et al.  Modulation of the Astrocyte-Neuron Lactate Shuttle System contributes to Neuroprotective action of Fibroblast Growth Factor 21 , 2020, Theranostics.

[10]  Tianyu Gong,et al.  Anti-neuroinflammatory Effect of Short-Chain Fatty Acid Acetate against Alzheimer's Disease via Upregulating GPR41 and Inhibiting ERK/JNK/NF-κB. , 2020, Journal of agricultural and food chemistry.

[11]  D. Bennett,et al.  The human brain NGF metabolic pathway is impaired in the pre-clinical and clinical continuum of Alzheimers disease , 2020, Molecular Psychiatry.

[12]  H. Yadav,et al.  Free Fatty Acid Receptors 2 and 3 as Microbial Metabolite Sensors to Shape Host Health: Pharmacophysiological View , 2020, Biomedicines.

[13]  Jamie L. Marshall,et al.  Disease-associated astrocytes in Alzheimer’s disease and aging , 2020, Nature Neuroscience.

[14]  J. Bogie,et al.  Fatty acid metabolism in the progression and resolution of CNS disorders. , 2020, Advanced drug delivery reviews.

[15]  R. Martins,et al.  Sodium Butyrate Reduces Brain Amyloid-β Levels and Improves Cognitive Memory Performance in an Alzheimer's Disease Transgenic Mouse Model at an Early Disease Stage. , 2020, Journal of Alzheimer's disease : JAD.

[16]  D. Holtzman,et al.  Gut Microbiota: From the Forgotten Organ to a Potential Key Player in the Pathology of Alzheimer’s Disease , 2019, The journals of gerontology. Series A, Biological sciences and medical sciences.

[17]  Bin Zhang,et al.  Large-scale proteomic analysis of Alzheimer’s disease brain and cerebrospinal fluid reveals early changes in energy metabolism associated with microglia and astrocyte activation , 2019, bioRxiv.

[18]  John C. Marioni,et al.  Unsupervised removal of systematic background noise from droplet-based single-cell experiments using CellBender , 2019, bioRxiv.

[19]  Wei Hu,et al.  Roles of forkhead box O (FoxO) transcription factors in neurodegenerative diseases: A panoramic view , 2019, Progress in Neurobiology.

[20]  J. Cummings,et al.  Alzheimer's disease drug development pipeline: 2019 , 2019, Alzheimer's & dementia.

[21]  J. Lippincott-Schwartz,et al.  Neuron-Astrocyte Metabolic Coupling Protects against Activity-Induced Fatty Acid Toxicity , 2019, Cell.

[22]  B. Vervliet,et al.  The role of short-chain fatty acids in microbiota–gut–brain communication , 2019, Nature Reviews Gastroenterology & Hepatology.

[23]  Abigail L. Paulson,et al.  Multi-sensory Gamma Stimulation Ameliorates Alzheimer’s-Associated Pathology and Improves Cognition , 2019, Cell.

[24]  M. Politis,et al.  Dementia spectrum disorders: lessons learnt from decades with PET research , 2019, Journal of Neural Transmission.

[25]  D. Butterfield,et al.  Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease , 2019, Nature Reviews Neuroscience.

[26]  Denis Gris,et al.  Astrocytes Maintain Glutamate Homeostasis in the CNS by Controlling the Balance between Glutamate Uptake and Release , 2019, Cells.

[27]  Patrice D Cani,et al.  Microbial regulation of organismal energy homeostasis , 2019, Nature Metabolism.

[28]  Hong Jiang,et al.  Dietary salt promotes cognitive impairment through tau phosphorylation , 2018, Nature.

[29]  Zev J. Gartner,et al.  DoubletFinder: Doublet detection in single-cell RNA sequencing data using artificial nearest neighbors , 2018, bioRxiv.

[30]  Angus M. Brown,et al.  Glia in brain energy metabolism: A perspective , 2018, Glia.

[31]  Paul Hoffman,et al.  Integrating single-cell transcriptomic data across different conditions, technologies, and species , 2018, Nature Biotechnology.

[32]  D. Butterfield,et al.  Oxidative Stress, Amyloid-β Peptide, and Altered Key Molecular Pathways in the Pathogenesis and Progression of Alzheimer’s Disease , 2018, Journal of Alzheimer's disease : JAD.

[33]  Pierre J. Magistretti,et al.  Lactate in the brain: from metabolic end-product to signalling molecule , 2018, Nature Reviews Neuroscience.

[34]  C. Rowe,et al.  Imaging tau and amyloid-β proteinopathies in Alzheimer disease and other conditions , 2018, Nature Reviews Neurology.

[35]  A. McKee,et al.  SIRT3 deregulation is linked to mitochondrial dysfunction in Alzheimer's disease , 2017, Aging cell.

[36]  E. Croteau,et al.  A cross-sectional comparison of brain glucose and ketone metabolism in cognitively healthy older adults, mild cognitive impairment and early Alzheimer's disease , 2017, Experimental Gerontology.

[37]  A. Bird,et al.  Radically truncated MeCP2 rescues Rett syndrome-like neurological defects , 2017, Nature.

[38]  E. Croteau,et al.  Can Ketones Help Rescue Brain Fuel Supply in Later Life? Implications for Cognitive Health during Aging and the Treatment of Alzheimer’s Disease , 2016, Front. Mol. Neurosci..

[39]  M. Norenberg,et al.  Glutamine Synthetase: Role in Neurological Disorders. , 2016, Advances in neurobiology.

[40]  C. Brayne,et al.  The nuclear retention of transcription factor FOXO3a correlates with a DNA damage response and increased glutamine synthetase expression by astrocytes suggesting a neuroprotective role in the ageing brain , 2015, Neuroscience Letters.

[41]  M. Dizdaroglu,et al.  Measurement of oxidatively induced DNA damage and its repair, by mass spectrometric techniques , 2015, Free radical research.

[42]  K. Lambertsen,et al.  Cytokine-producing microglia have an altered beta-amyloid load in aged APP/PS1 Tg mice , 2015, Brain, Behavior, and Immunity.

[43]  F. Bäckhed,et al.  Microbiota-Generated Metabolites Promote Metabolic Benefits via Gut-Brain Neural Circuits , 2014, Cell.

[44]  S. M. de la Monte.  Type 3 diabetes is sporadic Alzheimer׳s disease: mini-review. , 2014, European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology.

[45]  W. Garrett,et al.  The Microbial Metabolites, Short-Chain Fatty Acids, Regulate Colonic Treg Cell Homeostasis , 2013, Science.

[46]  F. Chaudhry,et al.  The system N transporter SN2 doubles as a transmitter precursor furnisher and a potential regulator of NMDA receptors , 2012, Glia.

[47]  M. G. Koerkamp,et al.  Modulation of glutamine metabolism by the PI(3)K–PKB–FOXO network regulates autophagy , 2012, Nature Cell Biology.

[48]  Guangchuang Yu,et al.  clusterProfiler: an R package for comparing biological themes among gene clusters. , 2012, Omics : a journal of integrative biology.

[49]  Pierre J Magistretti,et al.  Brain energy metabolism: focus on astrocyte-neuron metabolic cooperation. , 2011, Cell metabolism.

[50]  J. Quevedo,et al.  Behavioral and neurochemical effects of sodium butyrate in an animal model of mania , 2011, Behavioural pharmacology.

[51]  S. Salzberg,et al.  FLASH: fast length adjustment of short reads to improve genome assemblies , 2011, Bioinform..

[52]  C. Brayne,et al.  Microarray analysis of the astrocyte transcriptome in the aging brain: relationship to Alzheimer's pathology and APOE genotype , 2011, Neurobiology of Aging.

[53]  Wei Sun,et al.  The microbiome and butyrate regulate energy metabolism and autophagy in the mammalian colon. , 2011, Cell metabolism.

[54]  Dimitrios Kapogiannis,et al.  Disrupted energy metabolism and neuronal circuit dysfunction in cognitive impairment and Alzheimer's disease , 2011, The Lancet Neurology.

[55]  A. Fischer,et al.  Sodium butyrate improves memory function in an Alzheimer's disease mouse model when administered at an advanced stage of disease progression. , 2011, Journal of Alzheimer's disease : JAD.

[56]  E. Lam,et al.  Butyrate-rich Colonic Microenvironment Is a Relevant Selection Factor for Metabolically Adapted Tumor Cells* , 2010, The Journal of Biological Chemistry.

[57]  M. Citron,et al.  Alzheimer's disease: strategies for disease modification , 2010, Nature Reviews Drug Discovery.

[58]  C. Brayne,et al.  Astrocyte phenotype in relation to Alzheimer-type pathology in the ageing brain , 2010, Neurobiology of Aging.

[59]  C. Jack,et al.  Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade , 2010, The Lancet Neurology.

[60]  L. Mucke.  Neuroscience: Alzheimer's disease , 2009, Nature.

[61]  J. Tiedje,et al.  Naïve Bayesian Classifier for Rapid Assignment of rRNA Sequences into the New Bacterial Taxonomy , 2007, Applied and Environmental Microbiology.

[62]  M. Beal,et al.  Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases , 2006, Nature.

[63]  Jean-François Dartigues,et al.  The 9 year cognitive decline before dementia of the Alzheimer type: a prospective population-based study. , 2005, Brain : a journal of neurology.

[64]  R. Nicoll,et al.  Glutamine Uptake by Neurons: Interaction of Protons with System A Transporters , 2002, The Journal of Neuroscience.

[65]  S. Bröer,et al.  Transfer of glutamine between astrocytes and neurons , 2001, Journal of neurochemistry.

[66]  M. Hediger,et al.  Knockout of Glutamate Transporters Reveals a Major Role for Astroglial Transport in Excitotoxicity and Clearance of Glutamate , 1996, Neuron.

[67]  E. N. Bergman.  Energy contributions of volatile fatty acids from the gastrointestinal tract in various species. , 1990, Physiological reviews.

[68]  G. Macfarlane,et al.  Short chain fatty acids in human large intestine, portal, hepatic and venous blood. , 1987, Gut.